High acceptability and viral suppression of patients on Dolutegravir-based first-line regimens in pilot sites in Uganda: A mixed-methods prospective cohort study.

by Vennie Mbaziira Nabitaka, Pamela Nawaggi, Jennifer Campbell, James Conroy, Joseph Harwell, Kinanga Magambo, Caroline Middlecote, Benvy Caldwell, Cordelia Katureebe, Norah Namuwenge, Rita Atugonza, Andrew Musoke, Joshua Musinguzi
Published 2020-01-01

Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.

by Juliet Asio, Christine Watera, Norah Namuwenge, Wilford Kirungi, Joshua Musinguzi, Kaggwa Mugagga, Ronald Busobozi, Bridget Jolly Tusiime, Tom Lutalo, Edward Katongole Mbidde, Pontiano Kaleebu, Uganda HIV Drug Resistance Technical Working Group
Published 2020-01-01

Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.

by Pontiano Kaleebu, Wilford Kirungi, Christine Watera, Juliet Asio, Fred Lyagoba, Tom Lutalo, Anne A Kapaata, Faith Nanyonga, Chris M Parry, Brian Magambo, Jamirah Nazziwa, Maria Nannyonjo, Peter Hughes, Wolfgang Hladik, Anthony Ruberantwari, Norah Namuwenge, Joshua Musinguzi, Robert Downing, Edward Katongole-Mbidde, HIV Drug Resistance Working group
Published 2015-01-01